Physician profile
Stuart A Rosenberg
NPI 1326090853
$1,509.14
in general payments reported to CMS, 2019-2025
21 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $327 · 2023: $238 · 2024: $319 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734 · Travel and Lodging: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.85 |
| Travel and Lodging | $112.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $320.55 | 2024-2025 | Hydrofera Blue, Cutimed Sorbion, Sorbact Other |
| Astellas Pharma US INC | $169.88 | 2019-2020 | |
| Mimedx Group, INC. | $137.90 | 2025 | |
| Organogenesis INC. | $137.65 | 2023-2024 | Puraply, Puraply Am |
| Kci USA, INC. | $125.14 | 2023 | V.A.C. Dermatac, Activ.A.C., Kerramax Care |
| Advanced Oxygen Therapy INC. | $104.35 | 2025 | Topical Oxygen Chamber For Extremities |
| Pfizer INC. | $80.11 | 2019-2020 | |
| Janssen Biotech, INC. | $78.36 | 2019-2020 | |
| Blue Earth Diagnostics | $66.01 | 2019-2020 | |
| Abbvie INC. | $65.35 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $35.26 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $33.91 | 2019 | |
| Allergan, INC. | $28.95 | 2019-2020 | |
| Smith+Nephew, INC. | $20.67 | 2024 | Iodosorb Ointment 40g USA, Regranex, Collagenase Santyl |
| Axonics, INC. | $19.04 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.73 | 2019 | |
| Amgen INC. | $15.52 | 2019 | |
| Coloplast Corp | $15.36 | 2020 | |
| Antares Pharma, INC. | $13.81 | 2019 | |
| Endo Pharmaceuticals INC. | $13.71 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.